CANbridge Pharmaceuticals Inc. (HKG:1228)
Hong Kong · Delayed Price · Currency is HKD 1.950
0.00 (0.00%)
Jun 17, 2026, 2:38 PM HKT
CANbridge Pharmaceuticals Market Cap
CANbridge Pharmaceuticals has a market cap or net worth of 1.16 billion as of June 17, 2026. Its market cap has increased by 1,924.50% in one year.
Market Cap
1.16B
Enterprise Value
1.10B
Revenue
55.62M
Ranking
n/a
PE Ratio
58.41
Stock Price
1.95
Market Cap Chart
Since December 10, 2021, CANbridge Pharmaceuticals's market cap has decreased from 3.78B to 1.16B, a decrease of -69.24%. That is a compound annual growth rate of -22.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 1.16B | -11.26% |
| Dec 31, 2025 | 1.31B | 2,215.73% |
| Dec 31, 2024 | 56.50M | -86.56% |
| Dec 29, 2023 | 420.31M | -59.56% |
| Dec 30, 2022 | 1.04B | -72.41% |
| Dec 31, 2021 | 3.77B | -0.22% |
| Dec 10, 2021 | 3.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.71B |
| SinoMab BioScience | 1.66B |
| Mabpharm | 1.59B |
| Zhaoke Ophthalmology | 1.55B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.49B |
| Beijing Biostar Pharmaceuticals | 1.17B |
| Cutia Therapeutics | 1.16B |
| Kintor Pharmaceutical | 1.16B |